RE:RE:RE:RE:RE:RE:Question Thx Med...trader
I was curious how much news flow on Spectral makes it there and the likelihood that an average investor might stumble upon it.
It's a difficult stock to do your DD on , not to mention the mercurial nature of Sepsis itself and the difficulty in pinning down a solution particularly using a traditional 28-day mortality RCT to do so.
MM